Six-Year Outcomes After Transcatheter vs Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis - PubMed
7 days ago
- #TAVR
- #cardiac surgery
- #aortic stenosis
- The Evolut Low Risk trial compared TAVR and surgery in low-risk patients with severe aortic stenosis over 6 years.
- No significant difference was found in the composite endpoint of all-cause mortality or disabling stroke between TAVR (23.3%) and surgery (20.4%).
- TAVR had a higher reintervention rate at 6 years (5.5%) compared to surgery (3.3%), with the gap widening at 7 years (9.8% vs. 6.0%).
- The increased reintervention rate in TAVR was primarily due to higher incidence of aortic regurgitation (5.6% vs. 1.6%).
- The study was funded by Medtronic, and several authors disclosed financial ties to Medtronic and other medical device companies.